{"entity":{"type":"insider","cik":"0001557372","url":"/insider/0001557372","json_url":"/insider/0001557372.json","name":"OLER ABRAHAM N.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2019-11-26","last":"2022-01-31","span_basis":"filed_date"},"name_variants":[{"name":"OLER ABRAHAM N.","source":"filing","n_filings":11,"first_seen":"2019-11-26","last_seen":"2022-01-31"}],"transactions":[{"id":6293578,"accession":"0001179110-22-000652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-000652","line_url":"/filing/0001179110-22-000652#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":1.67,"price_display":"1.67","price_state":"stated","total_value":2505.0,"total_display":"2,505.00","shares_owned_after":24514.0,"shares_owned_after_display":"24,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-28","filed_date":"2022-01-31","scope":"insider"},{"id":6975514,"accession":"0001179110-22-000564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-000564","line_url":"/filing/0001179110-22-000564#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":3030.0,"total_display":"3,030.00","shares_owned_after":23014.0,"shares_owned_after_display":"23,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-24","scope":"insider"},{"id":6617820,"accession":"0001415889-22-000588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-000588","line_url":"/filing/0001415889-22-000588#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP CORP DEV & GEN COUNSEL)","officer_title":"SVP CORP DEV & GEN COUNSEL","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":3300.0,"total_display":"3,300.00","shares_owned_after":21514.0,"shares_owned_after_display":"21,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-18","scope":"insider"},{"id":6445549,"accession":"0001179110-22-000350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-000350","line_url":"/filing/0001179110-22-000350#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.39,"price_display":"2.39","price_state":"stated","total_value":3585.0,"total_display":"3,585.00","shares_owned_after":20014.0,"shares_owned_after_display":"20,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-10","scope":"insider"},{"id":4300453,"accession":"0001415889-21-005425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005425","line_url":"/filing/0001415889-21-005425#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP CORP DEV & GEN COUNSEL)","officer_title":"SVP CORP DEV & GEN COUNSEL","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":3160.0,"total_display":"3,160.00","shares_owned_after":18514.0,"shares_owned_after_display":"18,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-23","scope":"insider"},{"id":4466342,"accession":"0001179110-21-008982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-008982","line_url":"/filing/0001179110-21-008982#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2381.0,"shares_display":"2,381","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":10000.2,"total_display":"10,000.20","shares_owned_after":12515.0,"shares_owned_after_display":"12,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-28","filed_date":"2021-09-29","scope":"insider"},{"id":5379370,"accession":"0001179110-21-001785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-001785","line_url":"/filing/0001179110-21-001785#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","shares_owned_after":152000.0,"shares_owned_after_display":"152,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":2816761,"accession":"0001179110-20-011839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-011839","line_url":"/filing/0001179110-20-011839#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":9600.0,"total_display":"9,600.00","shares_owned_after":140000.0,"shares_owned_after_display":"140,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-14","scope":"insider"},{"id":2708581,"accession":"0001179110-20-011469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-011469","line_url":"/filing/0001179110-20-011469#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.256,"price_display":"0.26","price_state":"stated","total_value":5120.0,"total_display":"5,120.00","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-11-30","scope":"insider"},{"id":2527373,"accession":"0001179110-20-006359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-006359","line_url":"/filing/0001179110-20-006359#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (SVP Corp Dev & Gen Counsel)","officer_title":"SVP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":5550.0,"total_display":"5,550.00","shares_owned_after":90000.0,"shares_owned_after_display":"90,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-20","scope":"insider"},{"id":8723395,"accession":"0001179110-19-012054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-012054","line_url":"/filing/0001179110-19-012054#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001557372","owner_name":"OLER ABRAHAM N.","owner_url":"/insider/0001557372","role":"Officer (VP Corp Dev & Gen Counsel)","officer_title":"VP Corp Dev & Gen Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-26","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001130598","name":"Onconova Therapeutics, Inc.","url":"/issuer/0001130598","role":"Officer (SVP Corp Dev & Gen Counsel)","n_filings":11,"first_seen":"2019-11-26","last_seen":"2022-01-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001557372","retrieved_at":"2026-08-21T12:40:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}